Bio Protocol announced the acquisition of 6.9 million USD in funding from Maelstrom Fund and Animoca Brands to develop decentralized drug discovery methods that integrate AI, blockchain, and community engagement.
The initiative aims to address inefficiencies in traditional research systems. Critics indicate that current academic incentives are misaligned, which Bio Protocol seeks to rectify by providing an open platform for scientific exploration.
Leave a Reply